002898SZSE
🚨 Material Event

Announcement on Receiving the Decision to Terminate the Listing of Shares

*ST Sailong Co., Ltd.··4 pages

✨ AI Summary

The company received a decision from the Shenzhen Stock Exchange to terminate its stock listing due to financial performance issues. The stock will enter a delisting period from June 26, 2026, with the last trading day expected to be July 16, 2026. Investors are advised to manage their positions and related businesses before delisting.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 002898 Securities Abbreviation: *ST Sailong Announcement No.: 2026-069

Sailong Pharmaceutical Group Co., Ltd. Announcement on Receiving the Decision to Terminate the Listing of Shares

The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false records, misleading statements, or material omissions.

Special Notice:

  1. Type of securities to be delisted: RMB ordinary shares, Securities Abbreviation: *ST Sailong, Securities Code: 002898.
  2. Sailong Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") shares will resume trading on June 26, 2026, and enter the delisting consolidation period. The delisting consolidation period will be fifteen trading days, with the expected last trading day being July 16, 2026.
  3. During the delisting consolidation period, shares will be traded on the risk warning board. On the first trading day of the delisting consolidation period, there will be no price fluctuation limit for the company's shares. Thereafter, the daily price fluctuation limit will be 10%.
  4. Investors, securities companies, and other market participants are advised to settle stock pledge repurchase, agreed repurchase, margin financing, securities lending, and other businesses in a timely manner before the stock is delisted.
  5. For judicial freezing businesses that expire after the stock is delisted and before the initial registration period of the two-network company and delisted company board established and managed by the National Equities Exchange and Quotations Company Limited through the original securities company (hereinafter referred to as the "Delisted Board"), it is recommended that the competent authorities handle the renewal of freezing procedures in advance through the original execution assistance channels before the stock is delisted.

On June 17, 2026, the Company received the "Decision on Terminating the Listing of Shares of Sailong Pharmaceutical Group Co., Ltd." (Shenzhen Stock Exchange Letter [2026] No. 792) from the Shenzhen Stock Exchange. The Shenzhen Stock Exchange has decided to terminate the listing of the Company's shares. The relevant content is hereby announced as follows:

I. Type of Securities, Securities Abbreviation, and Securities Code for Delisting

  1. Type of Securities: RMB ordinary shares

  2. Securities Abbreviation: *ST Sailong

  3. Securities Code: 002898

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Sign in to read moreSee Pro pricing